Xavier Saelens, PhD

VIB-UGent, Belgium

Disclosure(s): ExeVir Bio: I am a scientific co-founder of ExeVir Bio and in receipt of ExeVir Bio share options, I am an inventor on patent applications WO2022/167666 A1 and WO2023/222825 A1 which incorporate discoveries and inventions described here.

Poster(s):

• (P-2023) A ‘Variant-Proof’ Cocktail Of Two Heavy Chain-Only Antibodies Targets 3 Epitopes In The Spike Protein S1 And S2 Subunits And Broadly Neutralizes SARS-Cov-2 With Exceptional Potency
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT